Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
American Woodmark
AMWD
$983M
| $33.4M | ﹤0.01% |
359,737
+15,959
| +5% | +$1.48M |
|
|
ALEX
1602
Alexander & Baldwin
ALEX
$1.35B
| $33.3M | ﹤0.01% |
1,751,888
+85,719
| +5% | +$1.63M |
|
1603
Syndax Pharmaceuticals
SNDX
$1.4B
| $33.2M | ﹤0.01% |
1,535,055
+174,135
| +13% | +$3.76M |
|
|
AGR
1604
DELISTED
Avangrid, Inc.
AGR
| $33.1M | ﹤0.01% |
1,022,336
+37,193
| +4% | +$1.21M |
|
1605
Bumble
BMBL
$709M
| $33.1M | ﹤0.01% |
2,245,966
+119,759
| +6% | +$1.77M |
|
1606
Orion
OEC
$539M
| $33.1M | ﹤0.01% |
1,194,042
+49,426
| +4% | +$1.37M |
|
1607
Descartes Systems
DSGX
$9.09B
| $33.1M | ﹤0.01% |
391,030
+15,954
| +4% | +$1.35M |
|
1608
Peloton Interactive
PTON
$3.09B
| $33.1M | ﹤0.01% |
5,430,706
+341,998
| +7% | +$2.08M |
|
1609
STAAR Surgical
STAA
$1.39B
| $33.1M | ﹤0.01% |
1,059,000
+52,787
| +5% | +$1.65M |
|
1610
AstraZeneca
AZN
$251B
| $33M | ﹤0.01% |
490,366
-710
| -0.1% | -$47.8K |
|
1611
Leonardo DRS
DRS
$11.1B
| $33M | ﹤0.01% |
1,645,681
+436,488
| +36% | +$8.75M |
|
1612
Hanesbrands
HBI
$2.23B
| $33M | ﹤0.01% |
7,390,620
+371,268
| +5% | +$1.66M |
|
1613
Addus HomeCare
ADUS
$2.06B
| $32.9M | ﹤0.01% |
354,654
+16,201
| +5% | +$1.5M |
|
|
BWIN
1614
Baldwin Insurance Group
BWIN
$2.2B
| $32.9M | ﹤0.01% |
1,370,252
+70,787
| +5% | +$1.7M |
|
1615
Prothena Corp
PRTA
$454M
| $32.9M | ﹤0.01% |
905,125
+46,065
| +5% | +$1.67M |
|
1616
Buckle
BKE
$3.09B
| $32.9M | ﹤0.01% |
691,814
+22,755
| +3% | +$1.08M |
|
1617
Green Plains
GPRE
$629M
| $32.9M | ﹤0.01% |
1,303,505
+56,011
| +4% | +$1.41M |
|
1618
Recursion Pharmaceuticals
RXRX
$2.17B
| $32.8M | ﹤0.01% |
3,325,985
+187,295
| +6% | +$1.85M |
|
1619
Brookfield Renewable
BEPC
$6.05B
| $32.7M | ﹤0.01% |
1,139,996
+40,375
| +4% | +$1.16M |
|
|
NVEE
1620
DELISTED
NV5 Global
NVEE
| $32.7M | ﹤0.01% |
1,175,596
+61,768
| +6% | +$1.72M |
|
1621
Stantec
STN
$12.7B
| $32.6M | ﹤0.01% |
405,848
+18,773
| +5% | +$1.51M |
|
1622
Donnelley Financial Solutions
DFIN
$1.52B
| $32.5M | ﹤0.01% |
521,376
+22,510
| +5% | +$1.4M |
|
1623
Live Oak Bancshares
LOB
$1.68B
| $32.5M | ﹤0.01% |
713,190
+32,347
| +5% | +$1.47M |
|
1624
ICU Medical
ICUI
$3.29B
| $32.4M | ﹤0.01% |
324,635
+803
| +0.2% | +$80.1K |
|
1625
Asana
ASAN
$3.17B
| $32.2M | ﹤0.01% |
1,691,497
+114,644
| +7% | +$2.18M |
|